Company profile
Medixall Group, Inc.
OTC: MDXL · Healthcare · Medical - Healthcare Information Services
#970 of 1,422 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ 24GM —SS 44
v0.1 · 25/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ filing timeliness, return on assets
Methodology →Revenue TTM
$304.3k
Rev growth YoY (TTM)
+29.4%
Net income (FY)
-$4.6M
Employees
7
as of 2026-08-26
Market cap
$719.3k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$309.4k$309.4k2023
Net income-$4.6M-$4.6M2023
Operating income-$684.1k-$684.1k2014
Total assets$201.1k$201.1k2023
Liabilities$6.7M$6.7M2023
Equity-$6.5M-$6.5M2023
Revenue trend
FY2014 – FY2023 · USD
FY14
FY17
FY18
FY19
FY21
FY21
FY22
FY23
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Medixall Group, Inc.’s revenue?
Medixall Group, Inc. booked $309.4k in FY2023 revenue, growing 422% year over year — faster than 93% of Healthcare companies we track, at a -1474.8% net margin.
Peers · Healthcare
Allarity Therapeutics, Inc.25DVyome Holdings, Inc.33DInteractive Health Network——Atai Beckley Inc.——Kane Biotech Inc.24DCannabis Bioscience International Holdings, Inc.18DKey facts
CEOTravis Jackson
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersLeesburg, FL
ExchangeOTC: MDXL
Employees7
IPO date2003-01-16
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.